| HOME | MEETINGS | MEMBERSHIP | EXHIBITORS | AWARDS | INFO | NEWS | ABOUT US | CONTACT | SIGN IN |
ensuring knowledge, enhancing quality
A 'not-for-profit' organisation,
run for pharmaceutical analysts by pharmaceutical analysts
run for pharmaceutical analysts by pharmaceutical analysts
| HOME | MEETINGS | MEMBERSHIP | EXHIBITORS | AWARDS | INFO | NEWS | ABOUT US | CONTACT | SIGN IN |
NEXT EVENT: Thursday 12th October 2017 - Stability Challenges III: Assuring the stability of medicines from manufacture t... 
JPAG - serving its members since 1970
JPAG plans and delivers events that address all aspects of pharmaceutical analysis and related facets of medicine control & registration.
NEXT EVENTS:
LAST EVENT:
JPAG plans and delivers events that address all aspects of pharmaceutical analysis and related facets of medicine control & registration.
NEXT EVENTS:
Thursday 12th October 2017
Stability Challenges III: Assuring the stability of medicines from manufacture to use
Royal Society of Chemistry, London
Continuing our successful Stability Challenges series, this meeting is the third in the series and is aimed at providing the latest information and best practice on many aspects of stability testing. In this particular meeting the focus will be on data evaluation, discussing the estimation and prediction of shelf lives, including physical stability, and the effects of temperature and humidity excursions. Also the efficient application of stability testing according to lean laboratory principles will be explored along with MHRA views on stability requirements and GMDP expectations.
The focus of this meeting is to examine best practice during the distribution and storage of medicines, to ensure correct storage conditions are maintained and to ensure the quality of the medicine is maintained during use in the clinic or by the patient. The generation of data to support temperature excursions and to demonstrate in-use stability will be explored.
This symposium will be of special interest to those engaged in Quality Control and Quality Assurance, pharmaceutical development, regulatory affairs, storage and distribution in the Pharmaceutical Industry, NHS manufacturing units, Contract Research Organisations, consulting, academia, and anyone else concerned with the management and assessment of drug stability.
Speakers:
Miles Ambler - GlaxoSmithKline
Francisco de Matos Afonso Pereira - MHRA
Dr Niels Hartvig - Novo Nordisk
Dr Samuel Kyeremateng - Abbvie
Dr Kristin Lehmkemper - Abbvie
Dr Nigel McSweeney - Cuspor
Dr Klimentina Pencheva - Pfizer
Dr Garry Scrivens - Pfizer
Dr Paul Whiteside - Pfizer
DETAILS AND BOOKING
Stability Challenges III: Assuring the stability of medicines from manufacture to use
Royal Society of Chemistry, London
Continuing our successful Stability Challenges series, this meeting is the third in the series and is aimed at providing the latest information and best practice on many aspects of stability testing. In this particular meeting the focus will be on data evaluation, discussing the estimation and prediction of shelf lives, including physical stability, and the effects of temperature and humidity excursions. Also the efficient application of stability testing according to lean laboratory principles will be explored along with MHRA views on stability requirements and GMDP expectations.
The focus of this meeting is to examine best practice during the distribution and storage of medicines, to ensure correct storage conditions are maintained and to ensure the quality of the medicine is maintained during use in the clinic or by the patient. The generation of data to support temperature excursions and to demonstrate in-use stability will be explored.
This symposium will be of special interest to those engaged in Quality Control and Quality Assurance, pharmaceutical development, regulatory affairs, storage and distribution in the Pharmaceutical Industry, NHS manufacturing units, Contract Research Organisations, consulting, academia, and anyone else concerned with the management and assessment of drug stability.
Speakers:
Miles Ambler - GlaxoSmithKline
Francisco de Matos Afonso Pereira - MHRA
Dr Niels Hartvig - Novo Nordisk
Dr Samuel Kyeremateng - Abbvie
Dr Kristin Lehmkemper - Abbvie
Dr Nigel McSweeney - Cuspor
Dr Klimentina Pencheva - Pfizer
Dr Garry Scrivens - Pfizer
Dr Paul Whiteside - Pfizer
DETAILS AND BOOKING
Tuesday 28th November 2017
The pharmaceutical analysis postgraduate research awards and careers symposium
Royal Society of Chemistry, London
JPAG presents its inaugural pharmaceutical analysis symposium for postgraduate students and early career stage scientists. This will provide the opportunity for delegates to showcase their work and network with peers, academics and industrial scientists through podium and poster presentations.The best podium and poster presentations will be recognised with cash prizes up to 500 GBP.
There will also be plenary lectures by leading scientists and an industrial careers exhibition:
» Professor Melissa Hanna-Brown
Prof Hanna-Brown is Technology & Innovation EU Lead, Pfizer Worldwide R&D, Sandwich, UK and Department of Chemistry, University of Warwick, UK and President of the Analytical Division, Royal Society Chemistry, UK.
» Professor Trevor Jones CBE
Prof Jones is Chairman of the international Clinical Research Organisation, Simbec-Orion, a member of the Boards of the Global Life Sciences investment company; Arix Bioscience; the Oxford based Drug Discovery Company ,e-Therapeutics; and the UK Stem Cell Foundation (UKSCF) .Formerly he was Director of Allergan Inc (USA) and R&D Director of The Wellcome Foundation.
Speakers:
Prof Melissa Hanna-Brown - Pfizer Global R&D
Prof Trevor Jones - King's College London
DETAILS AND BOOKING
The pharmaceutical analysis postgraduate research awards and careers symposium
Royal Society of Chemistry, London
JPAG presents its inaugural pharmaceutical analysis symposium for postgraduate students and early career stage scientists. This will provide the opportunity for delegates to showcase their work and network with peers, academics and industrial scientists through podium and poster presentations.The best podium and poster presentations will be recognised with cash prizes up to 500 GBP.
There will also be plenary lectures by leading scientists and an industrial careers exhibition:
» Professor Melissa Hanna-Brown
Prof Hanna-Brown is Technology & Innovation EU Lead, Pfizer Worldwide R&D, Sandwich, UK and Department of Chemistry, University of Warwick, UK and President of the Analytical Division, Royal Society Chemistry, UK.
» Professor Trevor Jones CBE
Prof Jones is Chairman of the international Clinical Research Organisation, Simbec-Orion, a member of the Boards of the Global Life Sciences investment company; Arix Bioscience; the Oxford based Drug Discovery Company ,e-Therapeutics; and the UK Stem Cell Foundation (UKSCF) .Formerly he was Director of Allergan Inc (USA) and R&D Director of The Wellcome Foundation.
Speakers:
Prof Melissa Hanna-Brown - Pfizer Global R&D
Prof Trevor Jones - King's College London
DETAILS AND BOOKING
Thursday 7th December 2017
Ensuring amorphous product quality: what are the challenges?
Royal Society of Chemistry, London
Amorphous drug formulation offers great promise in improving drug solubility - a major challenge in drug development. However, poor physical stability and hard to predict crystallisation remains key barriers for the wider use of amorphous solid solution in the pharmaceutical industry.
This symposium will critically examine the challenges and opportunities lie in the analysis of amorphous formulation systems.
Leading industrialists and academics will be sharing their experiences in the development, manufacturing and quality assurance of amorphous products.
New analytical technologies for the prediction of amorphous stability and novel PAT will be discussed.
You will gain latest knowledges on the analysis and manufacturing of amorphous/solid solution products.
You may form new collaborations with experts across academic and industry.
Speakers:
Prof Gavin Andrews - Queens University Belfast
Prof Duncan Craig - University College of London
Dr Korbinian Löbmann - University of Copenhagen
Dr Claire Pizzey - Diamond Light Source
Hans Platteeuw - Avivia
Dr Abhishek Singh - Johnson & Johnson
Dr Patrick Wray - BMS
DETAILS AND BOOKING
Ensuring amorphous product quality: what are the challenges?
Royal Society of Chemistry, London
Amorphous drug formulation offers great promise in improving drug solubility - a major challenge in drug development. However, poor physical stability and hard to predict crystallisation remains key barriers for the wider use of amorphous solid solution in the pharmaceutical industry.
This symposium will critically examine the challenges and opportunities lie in the analysis of amorphous formulation systems.
Leading industrialists and academics will be sharing their experiences in the development, manufacturing and quality assurance of amorphous products.
New analytical technologies for the prediction of amorphous stability and novel PAT will be discussed.
You will gain latest knowledges on the analysis and manufacturing of amorphous/solid solution products.
You may form new collaborations with experts across academic and industry.
Speakers:
Prof Gavin Andrews - Queens University Belfast
Prof Duncan Craig - University College of London
Dr Korbinian Löbmann - University of Copenhagen
Dr Claire Pizzey - Diamond Light Source
Hans Platteeuw - Avivia
Dr Abhishek Singh - Johnson & Johnson
Dr Patrick Wray - BMS
DETAILS AND BOOKING
Thursday 8th February 2018
Cleaning validation
Royal Society of Chemistry, London
Advance notice of this forthcoming symposium
DETAILS AND BOOKING
Cleaning validation
Royal Society of Chemistry, London
Advance notice of this forthcoming symposium
DETAILS AND BOOKING
LAST EVENT:
EXTERNAL EVENT: Tuesday 5th September 2017
JPAG at the APS 8th International PharmSci Conference
De Havilland Campus, University of Hertfordshire, Hatfield
To make a booking go to http://apsgb.org
DETAILS
JPAG at the APS 8th International PharmSci Conference
De Havilland Campus, University of Hertfordshire, Hatfield
To make a booking go to http://apsgb.org
DETAILS
Our only sponsors are our parent professional bodies:
Delegates of any JPAG symposia can access the speakers presentations.
Just SIGN IN, go to RESOURCES and look in MY PAST MEETINGS.
Just SIGN IN, go to RESOURCES and look in MY PAST MEETINGS.
Missed the meeting?
You can access a short report of recent meetings!
Just go to the MEETINGS page, go to PAST EVENTS. Then select the DETAILS for the meeting that interests you.
And do be sure to check the list of upcoming meetings so that you don't miss the next one!
You can access a short report of recent meetings!
Just go to the MEETINGS page, go to PAST EVENTS. Then select the DETAILS for the meeting that interests you.
And do be sure to check the list of upcoming meetings so that you don't miss the next one!
European Pharmaceutical Review
JPAG members can receive a free hard copy subscription to EPR
click here
JPAG members can receive a free hard copy subscription to EPR
click here
TESTIMONIALS:
Very enjoyable and thought-provoking day; going away with plenty of notes and specific items for discussion.
Excellent meeting, challenging and thought provoking. The organisation was excellent, thanks to all the efforts that JPAG team have made.
I have not attended a bad JPAG meeting yet. They are really good value for money and I really love to get the presentations as PDFs
LATEST NEWS:
Continuous manufacturing: regulatory and quality assurance challenges
Here is the latest article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "Continuous manufacturing: regulatory and quality assurance challenges ", co-written by Dr Dave Elder, Past-Chairman of the JP...
More...
Monday 11th September 2017
Here is the latest article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "Continuous manufacturing: regulatory and quality assurance challenges ", co-written by Dr Dave Elder, Past-Chairman of the JP...
More...
Monday 11th September 2017
Good Manufacturing Practice and mutual recognition
Here is the latest article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled Good Manufacturing Practice and mutual recognition ", written by Dr Dave Elder, Past-Chairman of the JPAG Committee. More...
Monday 11th September 2017
Here is the latest article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled Good Manufacturing Practice and mutual recognition ", written by Dr Dave Elder, Past-Chairman of the JPAG Committee. More...
Monday 11th September 2017
ICH M9: BCS-based biowaivers
Here is the latest article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "ICH M9: BCS-based biowaivers", written by Dr Dave Elder, Chairman of the JPAG Committee. More...
Monday 27th February 2017
Here is the latest article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "ICH M9: BCS-based biowaivers", written by Dr Dave Elder, Chairman of the JPAG Committee. More...
Monday 27th February 2017
COOKIES AND PERSONAL DATA:
This site does not use cookies.
However, it does securely hold details for those who register an account.
This information is only used by JPAG as described in the Privacy Statement (see link on footer below).
Follow us:
| Call us: | CONTACT US | Follow us: | | Terms and Conditions Privacy Statement |
| © Joint Pharmaceutical Analysis Group 2017 Website by Delta Consultancy Services |
|